DM0000: The mark consists of trade dress applied to one side of three-dimensional product packaging. At the top of the mark is the stylized wording "BAUSCH + LOMB" in purple, below which is the stylized wording "LUMIFY EYE ILLUMINATIONS" in gray. Below this wording is the design of a cosmetics tube with a purple body and gray top. Superimposed upon the design of the cosmetics tube is a semi-transparent purple rectangular shape with a missing bottom right corner. Inside the rectangular shape is the stylized white wording "HYDRA-GEL", below which is the stylized white wording "Brightening Eye Cream", below which is a purple horizontal line. Below this line is the stylized white wording "NIACINAMIDE + VITAMIN C + OPTIC BRIGHTENERS". Below the design of the cosmetics tube is the stylized white wording "CLINICALLY PROVEN & HYPOALLERGENIC". The mark has a gray background that becomes progressively darker from the top to the bottom. The dotted outline of the packaging and cosmetics tube packaging depicted in the center of the drawing is intended to show the position of the mark and is not part of the mark.
PM0001: BAUSCH PLUS LOMB LUMIFY EYE ILLUMINATIONS HYDRA GEL BRIGHTENING EYE CREAM NIACIAMIDE PLUS VITAMIN C PLUS OPTIC BRIGHTENERS CLINICALLY PROVEN AND HYPOALLERGENIC
GS0031: Cosmetic preparations; Eye cream; Non-medicated skin care preparations; all the aforementioned goods being hypoallergenic and containing niacinamide and vitamin C
CC0000: The color(s) gray, white, purple is/are claimed as a feature of the mark.
D10000: "EYE," "HYDRA-GEL," "BRIGHTENING EYE CREAM," "NIACINAMIDE + VITAMIN C + OPTIC BRIGHTENERS," and "CLINICALLY PROVEN & HYPOALLERGENIC"
Case File Event Statements
4/3/2024 - a month ago
15 - NOTIFICATION OF FINAL REFUSAL EMAILEDType:GNFN
4/3/2024 - a month ago
14 - FINAL REFUSAL E-MAILEDType:GNFR
4/3/2024 - a month ago
13 - FINAL REFUSAL WRITTENType:CNFR
2/12/2024 - 3 months ago
12 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
2/12/2024 - 3 months ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
2/12/2024 - 3 months ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA